Emerging Molecular Approaches to Pain Therapy

This publication has 91 references indexed in Scilit:

• 2-Nitrophenylcarbamoyl-(S)-prolyl-(S)-3-(2-naphthyl)alanyl-N-benzyl-N- methylamide (SDZ NKT 343), a Potent Human NK₁ Tachykinin Receptor Antagonist with Good Oral Analgesic Activity in Chronic Pain Models
  Journal of Medicinal Chemistry, 1998
• Broad-Spectrum, Non-Opioid Analgesic Activity by Selective Modulation of Neuronal Nicotinic Acetylcholine Receptors
  Science, 1998
• Spinal R -phenyl-isopropyl adenosine inhibits spinal dorsal horn neurons responding to noxious heat stimulation in the absence and presence of sensitization
  Pain, 1998
• Nerve growth factor: from neurotrophin to neurokine
  Trends in Neurosciences, 1996
• A unifying purinergic hypothesis for the initiation of pain
  The Lancet, 1996
• THE NF-κB AND IκB PROTEINS: New Discoveries and Insights
  Annual Review of Immunology, 1996
• Inhibition of NF-κB by Sodium Salicylate and Aspirin
  Science, 1994
• The vanilloid (capsaicin) receptor: Receptor types and species differences
  General Pharmacology: The Vascular System, 1994
• Nitric oxide evokes pain in humans on intracutaneous injection
  Neuroscience Letters, 1994
• Amantadine as N-methyl-d-aspartic acid receptor antagonist: new possibilities for therapeutic applications?
  Clinical Neurology and Neurosurgery, 1992